Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2026-01-29 @ 3:18 PM
Study NCT ID:
NCT00083668
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2004-05-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Schizophrenia | View |